Description:
Diroximel Fumarate is a prodrug of monomethyl fumarate in a controlled-release formulation that rapidly and efficiently converts to MMF in the body. It reduces the progressive damage to nerve cells via activating the Nrf2 pathway. It also acts as a NF-kappa B inhibitor.
- Molecular Weight:255.226
- Boiling Point:192-193
- Melting Point:102-106
- Purity:98%
Molecular Formula:
C11H13NO6
Canonical SMILES:
COC(=O)C=CC(=O)OCCN1C(=O)CCC1=O
InChI:
InChI=1S/C11H13NO6/c1-17-10(15)4-5-11(16)18-7-6-12-8(13)2-3-9(12)14/h4-5H,2-3,6-7H2,1H3/b5-4+
InChIKey:
YIMYDTCOUQIDMT-SNAWJCMRSA-N
Solubility:
Soluble in DMSO
Synonyms:
ALKS8700; ALKS 8700; ALKS-8700; 2-(2,5-Dioxopyrrolidin-1-yl)ethyl methyl fumarate; 4-O-[2-(2,5-dioxopyrrolidin-1-yl)ethyl] 1-O-methyl (E)-but-2-enedioate Weitere Informationen finden Sie
hier